Physician

Ahmad Zamael Amin, M.D.

According to 2025 Medicare claims, Ahmad Amin, M.D. (NPI: 1609037357) practices dermatology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60602-3430. Amin is affiliated with the Northwestern Medicine Physician Network ACO (ACO ID: A2620), participating under the MSSP model.

Amin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 481 traditional Medicare patients, billed 2,626 HCPCS/CPT codes, and received $135,427 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 857 prescription claims across 234 beneficiaries totaling $2,414,937 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 619 records totaling $829,458. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $111,424 and ending at $135,427. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $100,313 to $2,414,937. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	552	1,761	$111,424
2016	677	2,361	$160,031
2017	726	2,962	$199,667
2018	529	2,259	$166,865
2019	401	1,697	$101,652
2020	392	1,421	$93,387
2021	380	1,220	$86,328
2022	392	1,381	$87,547
2023	435	2,251	$115,159
2024	481	2,626	$135,427

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	254	687	$100,313
2016	273	772	$210,104
2017	346	1,063	$471,471
2018	262	976	$727,399
2019	231	872	$830,283
2020	209	661	$870,627
2021	199	622	$1,029,613
2022	207	693	$1,718,234
2023	232	820	$2,109,405
2024	234	857	$2,414,937

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	396	564	$99
17110	Destruction of skin growth, 1-14 growths	71	79	$78
17000	Destruction of precancer skin growth, 1 growth	149	187	$43
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	117	151	$13
17003	Destruction of precancer skin growth, 2-14 growths	99	445	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	55	1,540	$513,561
Skyrizi Pen	Risankizumab-Rzaa	19	1,484	$379,158
Cosentyx Sensoready (2 Pens)	Secukinumab	34	1,120	$307,839
Taltz Autoinjector	Ixekizumab	41	1,148	$278,889
Tremfya	Guselkumab	20	1,120	$248,287

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	617	$827,550	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$1,908	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Zamael Amin, M.D.?

Tedicare shows public-source Medicare data for Ahmad Zamael Amin, M.D. (NPI 1609037357), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Zamael Amin, M.D. have ACO affiliation data?

Ahmad Zamael Amin, M.D. is shown with ACO affiliation data for Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620).

What billing organization is linked to Ahmad Zamael Amin, M.D.?

Ahmad Zamael Amin, M.D. is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Ahmad Zamael Amin, M.D. have Open Payments data?

Ahmad Zamael Amin, M.D. has 619 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.